Human functional neuroimaging in nicotine and tobacco research: Basics, background, and beyond

Nicotine and Tobacco Research

Volumn 6, Issue 6, 2004, Pages 941-959

  McClernon, F Joseph ^a   Gilbert, David G ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBON 11; CLORGYLINE; DOPA; DOPAMINE; F A 85380; FLUORINE 18; GLUCOSE; IODINE 123; METHYLPHENIDATE; NICOTINE; NICOTINIC RECEPTOR; NOSE SPRAY; OXYGEN 15; PLACEBO; RACLOPRIDE; TOBACCO SMOKE; TRACER; UNCLASSIFIED DRUG;

AFFECT; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; COGNITION; COMORBIDITY; CONCEPT FORMATION; DIAGNOSTIC PROCEDURE; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; HUMAN; ISOTOPE LABELING; MAGNETOENCEPHALOGRAPHY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MENTAL DISEASE; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SPIN LABELING; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; WITHDRAWAL SYNDROME;

AFFECT; BRAIN; COGNITION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; GANGLIONIC STIMULANTS; HEMODYNAMIC PROCESSES; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL PROCESSES; MONOAMINE OXIDASE; NICOTINE; POSITRON-EMISSION TOMOGRAPHY; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 12344329638     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200412331337394     Document Type: Review

References (144)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. (4th-TR ed.). Washington, DC: Author.
2. Arthur, D., & Levin, E. D. (2002). Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: Impacts on memory and nicotine response. Psychopharmacology (Berl), 160, 140-145.
3. Ascher, J., Cole, J., & Colin, J. (1995). Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry, 56, 395-401.
4. Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002). Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in Neurobiology, 68, 209-245.
5. Balfour, D. J., Wright, A. E., Benwell, M. E, & Birrell, C. E, (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioural Brain Research, 113 73-83.
6. Benwell, M. E., Balfour, D. J., & Khadra, L. F. (1994). Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine. Journal of Clinical Investigation, 72 233-239.
7. Biederman, J., & Faraone, S. V. (2002). Current concepts on the neurobiology of attention-deficit/hyperactivity disorder. Journal of Attention Disorders, 6(Suppl. 1), S7-S16.
8. Bloom, A. S., Hoffmann, R. G., Fuller, S. A., Pankiewicz, J., Harsch, H. H., & Stein, E. A. (1999). Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model. Human Brain Mapping, 8, 235-244.
9. Bringmann, A. (1996). Behaviour-related effects of nicotine on slow EEG waves in basalnucleus-lesioned rats. Naunyn-Schmiedberg's Archives of Pharmacology, 353, 168-174.
10. Brody, A. L., Mandelkern, M. A., Lee, G., Smith, E., Sadeghi, M., Saxena, S., Jarvik, M. E., & London, E. D. (2004a). Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: A preliminary study. Psychiatry Research, 130, 269-281.
11. Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A. R., Lee, G. S., Bota, R. G., Ho, M. L., Saxena, S., Baxter, L. R. Jr., Madsen, D., & Jarvik, M. E. (2002). Brain metabolic changes during cigarette craving. Archives of General Psychiatry, 59, 1162-1172.
12. Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Maldelkern, M. A. (2004b). Smoking-induced ventral striatum dopamine release. American Journal of Psychiatry, 161, 1211-1218.
13. Buccino, G., Binkofski, F., Fink, G. R., Fadiga, L., Fogassi, L., Gallese, V., Seitz, R. J., Zilles, K., Rizzolatti, G., & Freund, H. J. (2001). Action observation activates premotor and parietal areas in a somatotopic manner: An fMRI study. European Journal of Neuroscience, 13, 400-404.
14. Buxton, R. B. (2002). Introduction to functional magnetic resonance imaging: Principles and techniques. Cambridge, England: Cambridge University Press.
15. Carr, L. A., & Basham, J. K. (1991). Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain. Life Sciences, 48, 1173-1177.
16. 2(15)O positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 22, 1149-1156.
17. Carter, B. L., & Tiffany, S. T. (1999). Meta-analysis of cue-reactivity in addiction research. Addiction, 94, 327-340.
18. Castellanos, F. X., & Tannock, R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nature Reviews Neuroscience, 3, 617-628.
19. Childress, A. R., Mozley, P. D., McElgin, W., Fitzgerald, J., Reivich, M., & O'Brien, C. P. (1999). Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry, 156, 11-18.
20. Coan, J. A., & Allen, J. J. B. (2003). The state and trait nature of frontal EEG asymmetry in emotion. In K. Hugdahl, & R. J. Davidson (Eds.), The asymmetrical brain (pp. 565-615). Cambridge, MA: MIT Press.
21. Cohen, R., Sweet, L., David, S., & Niama, R. (2004, February). Nicotine satiation and abstinence effects on fMRI brain activation during verbal working memory. Paper presented at the 10th Annual Meeting of the Society for Research on Nicotine and Tobacco, Scottsdale, AZ.
22. Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000). Nicotinic receptors in human brain: Topography and pathology. Journal of Chemical Neuroanatomy, 20, 281-298.
23. Dagher, A., Bleicher, C., Aston, J. A., Gunn, R. N., Clarke, P. B., & Cumming, P. (2001). Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse, 42, 48-53.
24. Dani, J. A., & De Biasi, M. (2001). Cellular mechanisms of nicotine addiction. Pharmacology, Biochemistry, and Behavior, 70, 439-446.
25. Davidson, R. J. (1995). Cerebral asymmetry, emotion, and affective style. In R. J. Davidson & K. Hugdahl (Eds.), Brain asymmetry (pp. 361-387). Cambridge, MA: MIT Press.
26. Davidson, J. R., Jackson, D. C., & Larson, C. L. (2000). Human electroencephalography. In J. T. Cacioppo, L. G. Tassinary & G. G. Bernston (Eds.), Handbook of psychophysiology (2nd ed., pp. 27-52). Cambridge, England: Cambridge University Press.
27. Domino, E. F. (1967). Electroencephalographic and behavioral arousal effects of small doses of nicotine: A neuropsychopharmacological study. Annals of the New York Academy of Sciences, 142, 216-244.
28. Domino, E. F., Minoshima, S., Guthrie, S., Ohl, L., Ni, L., Koeppe, R. A., & Zubieta, J. K. (2000a). Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse, 38, 313-321.
29. Domino, E. F., Minoshima, S., Guthrie, S. K., Ohl, L., Ni, L., Koeppe, R. A., Cross, D. J., & Zubieta, J. (2000b). Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience, 101, 277-282.
30. Domino, E. F., Ni, L., Xu, Y., Koeppe, R. A., Guthrie, S., & Zubieta, J. K. (2004). Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Progress in Neuro-psychopharmacology & Biological Psychiatry, 28, 319-327.
31. Due, D. L., Huettel, S. A., Hall, W. G., & Rubin, D. C. (2002). Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging. American Journal of Psychiatry, 159, 954-960.
32. Edwards, J. A., Wesnes, K., Warburton, D. M., & Gale, A. (1985). Evidence of more rapid stimulus evaluation following cigarette smoking. Addictive Behaviors, 10, 113-126.
33. Erblich, J., Lerman, C., Self, D. W., Diaz, G. A., & Bovbjerg, D. H. (2004). Stress-induced cigarette craving: Effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics Journal, 4, 102-109.
34. Ernst, M., Matochik, J. A., Heishman, S. J., Van Horn, J. D., Jons, P. H., Henningfield, J. E., & London, E. D. (2001). Effect of nicotine on brain activation during performance of a working memory task. Proceedings of the National Academy of Sciences of the United States of America, 98, 4728-4733.
35. Fabiani, M., Gratton, G., & Coles, M. G. H. (2000). Event-related brain potentials. In J. T. Cacioppo & L. G. Tassinary (Eds.), Handbook of psychophysiology (2nd ed., pp. 53-84). Cambridge, England: Cambridge University Press.
36. Fagen, Z. M., Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2003). Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine. Annals of the New York Academy of Sciences, 1003, 185-195.
37. Foulds, J., McSorley, K., Sneddon, J., Feyerabend, C., Jarvis, M. J., & Russell, M. A. (1994). Effects of subcutaneous nicotine injections on EEG alpha frequency in non-smokers: A placebo-controlled study. Psychopharmacology, 115, 163-166.
38. Fowler, J. S., Logan, J., Volkow, N. D., Wang, G. J., MacGregor, R. R., & Ding, Y. S. (2002). Monoamine oxidase: Radiotracer development and human studies. Methods, 27, 263-277.
39. Fowler, J. S., Logan, J., Wang, G. J., Franceschi, D., Volkow, N. D., Telang, F., Pappas, N., Ferrieri, R., Shea, C., Garza, V., Xu, Y., King, P., Schlyer, D., Gatley, S. J., Ding, Y. S., Warner, D., Netusil, N., Carter, P., Jayne, M., Alexoff, D., Zhu, W., & Vaska, P. (2003a). Monoamine oxidase A imaging in peripheral organs in healthy human subjects. Synapse, 49, 178-187.
40. Fowler, J. S., Logan, J., Wang, G. J., & Volkow, N. D. (2003b). Monoamine oxidase and cigarette smoking. Neurotoxicology, 24 75-82.
41. Fowler, J. S., Volkow, N. D., Logan, J., Pappas, N., King, P., MacGregor, R., Shea, C., Garza, V., & Gatley, S. J. (1998). An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo. Life Sciences, 63, PL19-PL23.
42. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., Warner, D., Zezulkova, I., & Cilento, R. (1996a). Inhibition of monoamine oxidase B in the brains of smokers. Nature, 379, 733-736.
43. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., & Wolf, A. P. (1996b). Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Sciences of the United States of America, 93, 14065-14069.
44. Fowler, J. S., Wang, G. J., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N., Shea, C., MacGregor, R. R., & Garza, V. (1999 . Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers. Nicotine & Tobacco Research, 1, 325-329.
45. Fowler, J. S., Wang, G. J., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N., Shea, C., MacGregor, R. R., & Garza, V. (2000 . Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. American Journal of Psychiatry, 157 1864-1866.
46. Gilbert, D. G. (1995). Smoking: Individual differences, psychopathology, and emotion. Washington, DC: Taylor and Francis.
47. Gilbert, D. G., Dibb, W. D., Plath, L. C., & Hiyane, S. G. (2000). Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilence. Psychophysiology, 37, 583-595.
48. Gilbert, D. G., Estes, S. L., & Welser, R. (1997). Does noise stress modulate effects of smoking/nicotine? Mood, vigilance, and EEG responses. Psychopharmacology (Berl), 129, 382-389.
49. Gilbert, D. G., McClernon, F. J., Rabinovich, N. E., Dibb, W. D., Plath, L. C., Hiyane, S., Jensen, R. A., Meliska, C. J., Estes, S. L., & Gehlbach, B. A. (1999). EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: Relations to depressive traits, nicotine exposure, and dependence. Experimental and Clinical Psychopharmacology, 7, 427-443.
50. Gilbert, D. G., McClernon, F. J., Rabinovich, N. E., Plath, L. C., Jensen, R. A., & Meliska, C. J. (1998). Effects of smoking abstinence on mood and craving in men: Influences of negative-affect-related personality traits, habitual nicotine intake and repeated measurements. Personality & Individual Differences, 25, 399-423.
51. Gilbert, D. G., McClernon, F. J., Rabinovich, N. E., Plath, L. C., Masson, C. L., Anderson, A. E., & Sly, K. F. (2002). Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. Journal of Consulting and Clinical Psychology, 70, 142-152.
52. Gilbert, D. G., McClernon, F. J., Rabinovich, N. E., Sugai, C., Plath, L. C., Asgaard, G., Zuo, Y., Huggenvik, J., & Bortos, N. (2004a). Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine & Tobacco Research, 6, 249-267.
53. Gilbert, D. G., Rabinovich, N. E., Sugai, C., Huggenvik, J. I., & Jameson, T. (2004b). Affective, cognitive, and EEG consequences of nicotine patch across 45 days of smoking abstinence: Influences of DRD2 genotype and depressive traits. Paper session at the 10th Annual Meeting of the Society for Research on Nicotine and Tobacco. Scottsdale, AZ.
54. Gilbert, D. G., Robinson, J. H., Chamberlin, C. L., & Spielberger, C. D. (1989). Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie. Psychophysiology, 26, 311-320.
55. Gilbert, D. G., Sugai, C., Zuo, Y., Eau Claire, N., McClernon, F. J., Rabinovich, N. E., Markus, T., Asgaard, G., & Radtke, R. (in press). Effects of nicotine on brain responses to emotional pictures. Nicotine & Tobacco Research.
56. Gilbert, D. G., Sugai, C., Zuo, Y., Rabinovich, N. E., & McClernon, F. J. (2004c). Nicotine patch reduces distraction by smoking and negatively valenced picture distractors, during a RVIP task: A P300 study. Manuscript in preparation.
57. Gilbert, D. G., Zuo, Y., Browning, R. A., Shaw, T. M., Rabinovich, N. E., Gilbert-Johnson, A. M., & Plath, L. (2003). Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence. Nicotine & Tobacco Research, 5, 813-819.
58. Glautier, S., & Tiffany, S. T. (1995). Methodological issues in cue reactivity research. In D. C. Drummond & S. T. Tiffany (Eds.), Addictive behaviour: Cue exposure theory and practice (pp. 75-97 . New York: John Wiley & Sons.
59. Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry, 160, 636-645.
60. Griesar, W. S., Zajdel, D. P., & Oken, B. S. (2002). Nicotine effects on alertness and spatial attention in non-smokers. Nicotine & Tobacco Research, 4, 185-194.
61. Heath, A. C., & Madden, P. A. F. (1995). Genetic influences on smoking behavior. In J. R. Turner & L. R. Cardon (Eds.), Behavior genetic approaches in behavioral medicine. Perspectives on individual differences (pp.45-66). New York: Plenum.
62. Heller, W., Schmidtke, J. I., Nitschke, J. B., Koven, N. S., & Miller, G. A. (2002). States, traits, and symptoms: Investigating the neural correlates of emotion, personality, and psychopathology. In D. Cervone & W. Mischel (Eds.), Advances in personality science (pp. 106-126). New York: Guilford Press.
63. Hommer, D. W. (1999). Functional imaging of craving. Alcohol Research & Health, 23, 187-196.
64. Houlihan, M. E., Pritchard, W. S., & Robinson, J. H. (1996a). Faster P300 latency after smoking in visual but not auditory oddball tasks. Psychopharmacology, 123, 231-238.
65. Huettel, S. A., Song, A. W., & McCarthy, G. (2004). Functional magnetic resonance imaging. Sunderland, MA: Sinauer Associates.
66. Hutchison, K. E., LaChance, H., Niaura, R., Bryan, A., & Smolen, A. (2002). The DRD4 VNTR polymorphism influences reactivity to smoking cues. Journal of Abnormal Psychology, 111, 134-143.
67. Isreal, J. B., Chesney, G. L., Wickens, C. D., & Donchin, E. (1980). P300 and tracking difficulty: Evidence for multiple resources in dual-task performance. Psychophysiology, 17, 259-273.
68. Jezzard, P., Matthews, P. M., & Smith, S. M. (Eds.). (2001). Functional MRI: An introduction to methods. Oxford, England: Oxford University Press.
69. Jezzard, P., & Song, A. W. (1996). Technical foundations and pitfalls of clinical fMRI. Neuroimage, 4, S63-S75.
70. Jones, G. M. M., Sahakaian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology, 108, 485-494.
71. Jonides, J., Schumacher, E. H., Smith, E. E., Lauber, E. J., Awh, E., & Minoshima, S., et al. (1997). Verbal working memory load affects regional brain activation as measured by PET. Journal of Cognitive Neuroscience, 9, 462-475.
72. Juliano, L. M., & Brandon, T. H. (1998). Reactivity to instructed smoking availability and environmental cues: Evidence with urge and reaction time. Experimental and Clinical Psychopharmacology, 6, 45-53.
73. Kimes, A. S., Horti, A. G., London, E. D., Chefer, S. I., Contoreggi, C., & Ernst, M., et al. (2003). 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. Journal of the Federation of American Societies for Experimental Biology, 17, 1331-1333.
74. Klimesch, W. (1999). EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Research Reviews, 29, 169-195.
75. Knott, V. J. (1987). Acute effects of tobacco on human brain stem evoked potentials. Addictive Behaviors, 12, 375-379.
76. Knott, V. J. (1989a). Brain electrical imaging the dose-response effects of cigarette smoking. Neuropsychobiology, 22, 236-242.
77. Knott, V. J. (1989b). Brain event-related potentials (ERPs) in smoking performance research. In T. Ney & A. Gale (Eds.), Smoking and human behavior (pp. 93-114). Chichester, England: John Wiley & Sons.
78. Knott, V. J. (1990). A neuroelectric approach to the assessment of psychoactivity in comparative substance use. In D. M. Warburton (Ed.), Addiction controversies (pp. 66-89). New York: Harwood Academic Publishers.
79. Knott, V., Bakish, D., Lusk, S., & Barkely, J. (1997). Relaxation-induced EEG alterations in panic disorder patients. Journal of Anxiety Disorders, 11, 365-376.
80. Knott, V., Bosman, M., Mahoney, C., Ilivitsky, V., & Quirt, K. (1999). Transdermal nicotine: Single dose effects on mood, EEG, performance, and event-related potentials. Pharmacology, Biochemistry, and Behavior, 63, 253-261.
81. Knott, V. J., Harr, A., Ilivitsky, V., & Mahoney, C. (1998). The cholinergic basis of the smoking-induced EEG activation profile. Neuropsychobiology, 38, 97-107.
82. Knott, V. J., Hooper, C., Lusk-Mikkelsen, S., & Kerr, C. (1995). Variations in spontaneous brain electrical (EEG) topography related to cigarette smoking: Acute smoking, drug comparisons, cholinergic transmission, individual differences and psychopathology (pp. 167-189). In E. F. Domino (Ed.), Brain imaging of nicotine and tobacco smoking. Ann Arbor, MI: NPP Books.
83. Knott, V. J., Kerr, C., Hooper, C., & Lusk-Mikkelsen, S. (1995). Cigarette smoking and event-related brain electrical potential (ERP) topographies associated with attentional-distractive processes. In E. F. Domino (Ed.), Brain imaging of nicotine and tobacco smoking (pp. 191-221). Ann Arbor, MI: NPP Books.
84. Knott, V. J., Mahoney, C., Kennedy, S., & Evans, K. (2002). EEG correlates of acute and chronic paroxetine treatment in depression. Journal of Affective Disorders, 69, 241-249.
85. Knott, V. J., & Venables, P. H. (1977). EEG alpha correlates of nonsmokers, smokers smoking and smoking deprivation. Psychophysiology, 14, 150-156.
86. Krause, K. H., Dresel, S. H., Krause, J., Kung, H. F., Tatsch, K., & Ackenheil, M. (2002). Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. International Journal of Neuropsychopharmacology, 5, 111-113.
87. Kumari, V., Gray, J. A., Ffytche, D. H., Mitterschiffthaler, M. T., Das, M., Zachariah, E., Vythelingum, G. N., Williams, S. C., Simmons, A., & Sharma, T. (2003). Cognitive effects of nicotine in humans: An fMRI study. Neuroimage, 19, 1002-1013.
88. Larson, C. L., Davidson, R. J., Abercrombie, H. C., Ward, R. T., Schaefer, S. M., Jackson, D. C., Holden, J. E., & Perlman, S. B. (1998). Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power. Psychophysiology, 35, 162-169.
89. Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association, 284, 2606-2610.
90. Lawrence, N. S., Ross, T. J., & Stein, E. A. (2002). Cognitive mechanisms of nicotine on visual attention. Neuron, 36, 539-548.
91. Le Houezec, J., Halliday, R., Benowitz, N. L., Callaway, E., Naylor, H., & Herzig, K. (1994). A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology, 114, 628-634.
92. Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., & Shields, P. G. (1998). Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychology, 17, 56-62.
93. Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., Niaura, R., & Epstein, L. (2002). Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics, 12, 627-634.
94. Levin, E. D., & Rezvani, A. H. (2002). Nicotinic treatment for cognitive dysfunction. Current Drug Targets - CNS & Neurological Disorders, 1, 423-431.
95. Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001). Neurophysiological investigation of the basis of the fMRI signal. Nature, 412, 150-157.
96. London, E. D., Cascella, N. G., Wong, D. F., Phillips, R. L., Dannals, R. F., Links, J. M., Herning, R., Grayson, R., Jaffe, J. H., & Wagner, H. N. Jr. (1990). Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Archives of General Psychiatry, 47, 567-574.
97. Lucas-Meunier, E., Fossier, P., Baux, G., & Amar, M. (2003). Cholinergic modulation of the cortical neuronal network. Pflugers Archiv: European Journal of Physiology, 446, 17-29.
98. Maas, L. C., Lukas, S. E., Kaufman, M. J., Weiss, R. D., Daniels, S. L., Rogers, V. W., Kukes, T. J., & Renshaw, P. F. (1998). Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. American Journal of Psychiatry, 155, 124-126.
99. Madsen, D., Bramen, J., Jarvik, M., Olmstead, R., London, E. D., Rose, J. E., & Cohen, M. S. (2004). A method of naturalistic smoke delivery for use in functional MRI: The MR hookah. Manuscript submitted for publication.
100. Mangan, G. L., & Golding, J. (1978). An enhancement model of smoking maintenance. In R. E. Thorton (Ed.), Smoking behaviour: Physiological and psychological influence (pp. 87-114). Edinburgh, Scotland: Churchill-Livingstone.
101. McClernon, F. J., Hiott, F. B., Huettel, S. A., & Rose, J. E. (2004). Brain responses to control but not smoking cues are altered by short-term abstinence. Manuscript in preparation.
102. McCormick, D. A., & Bal, T. (1997). Sleep and arousal: Thalamocortical mechanisms. Annual Review of Neuroscience, 20, 185-215.
103. McDonough, B. E., & Warren, C. A. (2001). Effects of 12-h tobacco deprivation on event-related potentials elicited by visual smoking cues. Psychopharmacology (Berl), 154, 282-291.
104. McEvoy, J. P., & Allen, T. B. (2002). The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Current Drug Targets - CNS & Neurological Disorders, 1, 433-442.
105. Michel, C., & Bättig, K. (1989). Separate and combined psychophysiological effects of cigarette smoking and alcohol consumption. Psychopharmacology, 97, 65-73.
106. Murphree, H. B., Pfeiffer, C. C., & Price, L. M. (1967). Electroencephalographic changes in man following smoking. Annals of the New York Academy of Sciences, 142, 245-260.
107. Näätänen, R. (1982). Processing negativity: An evoked-potential reflection of selective attention. Psychological Bulletin, 92, 60-640.
108. Nadeau, S. E., & Crosson, B. (1995). A guide to the functional imaging of cognitive processes. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 8, 143-162.
109. Nordberg, A., Amberla, K., Shigeta, M., Lundqvist, H., Viitanen, M., Hellstrom-Lindahl, E., Johansson, M., Andersson, J., Hartvig, P., Lilja, A., Langstrom, B., & Winblad, B. (1998). Long-term tacrine treatment in three mild Alzheimer patients: Effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Disease & Associated Disorders, 12, 228-237.
110. Nordberg, A., Lundqvist, H., Hartvig, P., Andersson, J., Johansson, M., Hellstrom-Lindahi, E., & Langstrom, B. (1997). Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: Effect of tacrine treatment. Dementia and Geriatric Cognitive Disorders, 8, 78-84.
111. Nybäck, H., Nordberg, A., Langstrom, B., Halldin, C., Hartvig, P., Ahlin, A., Swahn, C. G., & Sedvall, G. (1989). Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Progress in Brain Research, 79, 313-319.
112. Oreland, L., Fowler, C. J., & Schalling, D. (1981). Low platelet monoamine oxidase activity in cigarette smokers. Life Sciences, 29, 2511-2518.
113. Pascual-Marqui, R. D., Esslen, M., Kochi, K., & Lehmann, D. (2002). Functional imaging with low-resolution brain electromagnetic tomography (LORETA): A review. Methods and Findings in Experimental and Clinical Pharmacology, 24(Suppl. C), 91-95.
114. Paterson, D., & Nordberg, A. (2000). Neuronal nicotinic receptors in the human brain. Progress in Neurobiology, 61, 75-111.
115. Pearlson, G. D., Jeffery, P. J., Harris, G. J., Ross, C. A., Fischman, M. W., & Camargo, E. E. (1993). Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. American Journal of Psychiatry, 150, 495-497.
116. Perkins, K. A., Gerlach, D., Vender, J., Grobe, J., Meeker, J., & Hutchison, S. (2001). Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine and Tobacco Research, 3, 141-150.
117. Pfurtscheller, G., & Lopes da Silva, F. H. (1999). Event-related EEG/MEG synchronization and desynchronization: Basic principles. Clinical Neurophysiology, 110, 1842-1857.
118. Pickworth, W. B., Herning, R. I., & Henningfield, J. E. (1989). Spontaneous EEG changes during tobacco abstinence and nicotine substitution in human volunteers. Journal of Pharmacology and Experimental Therapeutics, 251, 976-982.
119. Pritchard, W. S., Sokhadze, E., & Houlihan, M. E. (2004). Effects of nicotine on event-related potentials (ERPs): A review. Manuscript submitted for publication.
120. Rose, J. E., Behm, F. M., Ramsey, C., & Ritchie, J. C., Jr. (2001). Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine & Tobacco Research, 3, 383-390.
121. Rose, J. E., Behm, F. M., Westman, E. C., & Johnson, M. (2000). Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry, and Behavior, 67, 71-81.
122. Rose, J. E., Behm, F. M., Westman, E. C., Mathew, R. J., London, E. D., Hawk, T. C., Turkington, T. G., & Coleman, R. E. (2003). PET studies of the influences of nicotine on neural systems in cigarette smokers. American Journal of Psychiatry, 160, 323-333.
123. Saletu, B. (1987). The use of pharmaco-EEG in drug profiling. In I. Hindmarch & P. Stonier (Eds.), Human Psychopharmacology: Measures and methods, Vol. 1 (pp. 173-200). Chichester, England: John Wiley & Sons.
124. Salokangas, R. K., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvalahti, E., & Hietala, J. (2000). High levels of dopamine activity in the basal ganglia of cigarette smokers. American Journal of Psychiatry, 157, 632-634.
125. Spielberger, C. D. (1986). Psychological determinants of smoking behavior. In R. D. Tollison (Ed.), Smoking and society: Toward a more balanced assessment (pp. 89-134). Lexington, MA: D. C. Heath.
126. Staley, J. K., Krishnan-Sarin, S., Zoghbi, S., Tamagnan, G., Fujita, M., Seibyl, J. P., Maciejeski, P. K., O'Malley, S., & Innis, R. B. (2001). Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse, 41, 275-284.
127. Stapleton, J. M., Gilson, S. F., Wong, D. F., Villemagne, V. L., Dannals, R. F., Grayson, R. F., Henningfield, J. E., & London, E. D. (2003). Intravenous nicotine reduces cerebral glucose metabolism: Preliminary study. Neuropsychopharmacology, 28, 765-772.
128. Stein, E. A., Pankiewiez, J., Harsch, H. H., Cho, J. K., Fuller, S. A., Hoffmann, R. G., Hawkins, M.I., Rao, S. M., Bandettini, P. A., & Bloom, A. S. (1998). Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. American Journal of Psychiatry, 155, 1009-1015.
129. U.S. Department of Health and Human Services. (2004). The health consequences of smoking: A report of the Surgeon General. Retrieved September 10, 2004, from http://www.cdc.gov/tobacco/sgr/sgr_2004/index.htm
130. Volkow, N. D., Fowler, J. S., & Wang, G. J. (2003). The addicted human brain: Insights from imaging studies. Journal of Clinical Investigations, 111, 1444-1451.
131. Volkow, N. D., Wang, G. J., Hitzemann, R., Fowler, J. S., Pappas, N., Lowrimore, P., Burr, G., Pascani, K., Overall, J., & Wolf, A. P. (1995). Depression of thalamic metabolism by lorazepam is ?associated with sleepiness. Neuropsychopharmacology, 12, 123-32.
132. Wallace, E. A., Wisniewski, G., Zubal, G., van Dyck, C. H., Pfau, S. ?E., Smith, E. O., Rosen, M. I., Sullivan, M. C., Woods, S. ?W., & Kosten, T. R. (1996). Acute cocaine effects on absolute ?cerebral blood flow. Psychopharmacology (Berl), 128, 17-20.
133. Walker, D., Mahoney, C., Llivitsky, V., & Knott, V. J. (2001). Effects ?of haloperidol pretreatment on the smoking-induced EEG/mood activation response profile. Neuropsychobiology, 43, 102-112.
134. Warburton, D. M. (1998). Caffeine, nicotine and attentional performance. In J. Snel & M. Lorist (Eds.), Nicotine, caffeine and social drinking: Behaviour and brain function (pp. 245-256). London: Harwood Publishers.
135. Warren, C. A., & McDonough, B. E. (1999). Event-related brain potentials as indicators of smoking cue-reactivity. Clinical Neurophysiology, 110, 1570-1584.
136. Wesnes, K., & Warburton, D. M. (1984). Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology, 82, 338-342.
137. Wetter, D. W., Fiore, M. C., Young, T. B., McClure, J. B., de Moor, C. A., & Baker, T. B. (1999). Gender differences in response to nicotine replacement therapy: Objective and subjective indexes of tobacco withdrawal. Experimental and Clinical Psychopharmacology, 7, 135-144.
138. Wheless, J. W., Castillo, E., Maggio, V., Kim, H. L., Breier, J. I., Simos, P. G., & Papanicolaou, A. C. (2004). Magnetoencephalography (MEG) and magnetic source imaging (MSI). Neurologist, 10, 138-153.
139. Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L., & Jones, I. W. (2000). Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. European Journal of Pharmacology, 393, 51-58.
140. Wonnacott, S., Mogg, A., Bradley, A., & Jones, I. W. (2002). Presynaptic nicotinic acetylcholine receptors: Subtypes mediating neurotransmitter release. In E. D. Levin (Ed.), Nicotinic receptors in the nervous system (pp. 30-49). Boca Raton, FL: CRC Press.
141. World Bank. (1999). Curbing the epidemic: Governments and the economics of tobacco control. Retrieved September 10, 2004, from http://www1.worldbank.org/tobacco/).
142. Wrase, J., Grusser, S. M., Klein, S., Diener, C., Hermann, D., Flor, H., Mann, K., Brans, D. F., & Heinz, A. (2002). Development of alcohol-associated cues and cue-induced brain activation in alcoholics. European Psychiatry, 17, 287-291.
143. Zinser, M. C., Fiore, M. C., Davidson, R. J., & Baker, T. B. (1999). Manipulating smoking motivation: Impact on an electrophysiological index of approach motivation. Journal of Abnormal Psychology, 108, 240-254.
144. Zubieta, J., Lombardi, U., Minoshima, S., Guthrie, S., Ni, L., Ohl, L. E., Koeppe, R. A., & Domino, E. F. (2001). Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biological Psychiatry, 49, 906-913.